emerg
need
search
possibl
medic
method
util
avail
sequenc
inform
homolog
model
slico
dock
number
avail
medic
might
prove
effect
inhibit
two
main
drug
target
spike
glycoprotein
proteas
result
sever
compound
determin
silico
dock
model
might
prove
effect
inhibitor
sever
antivir
medic
zanamivir
indinavir
saquinavir
remdesivir
show
potenti
pro
main
proteinas
inhibitor
treatment
conclus
zanamivir
indinavir
saquinavir
remdesivir
among
excit
hit
pro
main
proteinas
also
excit
uncov
flavin
adenin
dinucleotid
fad
adeflavin
defici
medicin
coenzym
coenzym
may
also
potenti
use
treatment
infect
use
offlabel
medic
may
benefici
treatment
world
health
organ
declar
global
emerg
pandem
coronaviru
diseas
activ
spread
around
globe
caus
viru
caus
symptom
fever
cough
pneumonia
nausea
fatigu
reach
countri
around
globe
case
confirm
march
epidemiolog
background
viru
thought
stem
seafood
market
wuhan
china
howev
true
epicent
initi
transfer
human
still
unknown
current
complet
genom
sequenc
known
ncbi
genbank
countri
variat
sequenc
less
viru
close
relat
sarscov
allow
util
known
protein
structur
quickli
build
model
drug
discoveri
new
tradit
method
drug
discoveri
could
take
year
approach
taken
search
possibl
medic
silico
dock
model
variabl
protein
spike
glycoprotein
main
proteas
cov
spike
protein
bind
host
cell
membran
receptormedi
interact
allow
entranc
host
cell
comput
determin
similar
mechan
sar
viru
receptor
highest
affin
angiotensinconvert
enzym
structur
similar
spike
protein
sar
spike
protein
conserv
variabl
host
cell
interact
region
protein
current
crystal
structur
avail
spike
protein
employ
homolog
model
util
sar
spike
protein
pdb
templat
second
silico
dock
model
pro
main
proteas
respons
control
sever
major
function
viru
highli
conserv
catalyt
domain
sar
viru
function
includ
replic
process
viru
make
ideal
target
drug
develop
main
proteas
determin
ref
pdb
protein
spike
proteas
essenti
transmiss
virul
viru
inhibit
anyon
two
protein
higher
activ
therapi
sever
infect
reduc
effort
place
competit
inhibit
bind
natur
substrat
librari
known
bioactiv
compound
run
sever
site
spike
protein
catalyt
site
main
proteas
util
approv
compound
databas
quick
trial
compound
minim
effort
approv
food
drug
agenc
could
carri
chosen
run
databas
classifi
approv
drug
major
jurisdict
includ
fda
ie
drugbank
approv
databas
cover
major
bioactiv
pharmaceut
compound
util
around
globe
current
entri
molecular
dock
calcul
complet
use
dock
suit
maestro
new
york
ny
usa
version
mmshare
version
releas
platform
use
virtual
screen
workflow
workflow
util
three
dock
precis
htv
sp
xp
yield
top
hit
bind
site
protein
prepar
restrain
minim
use
forc
field
grid
site
creat
use
receptor
grid
gener
dock
length
grid
center
determin
activ
resid
target
protein
ligand
prepar
use
forc
field
possibl
state
gener
ph
dock
score
report
kcalmol
neg
number
better
bind
surfac
glycoprotein
wuhan
seafood
market
pneumonia
viru
sequenc
id
structur
model
use
modbas
util
model
structur
model
sequenc
ncbi
access
upload
modbas
interfac
run
templat
sar
spike
protein
receptor
bind
domain
pdb
chain
e
sequenc
ident
found
fig
calcul
complet
import
structur
minim
use
forc
field
overlay
pre
post
minim
structur
seen
fig
sequenc
reveal
similar
sarscov
viru
allow
genom
proteom
homolog
comparison
use
homolog
model
abl
develop
model
spike
glycoprotein
fig
model
allow
us
perform
dock
calcul
util
databas
known
bioactiv
approv
compound
model
modbas
program
abl
use
homologu
sar
spike
protein
pdb
origin
sequenc
genbank
construct
spike
protein
protein
run
restrict
minim
process
util
schroding
dock
protein
prepar
allow
side
chain
place
energet
favor
conform
fig
effort
stop
interact
sever
site
determin
target
spike
protein
dock
studi
three
site
locat
interact
point
specif
hydrogen
bond
calcul
main
intermolecular
forc
interact
fourth
alloster
site
determin
surfac
map
protein
locat
bind
site
chosen
would
caus
destruct
interact
site
label
site
inform
site
seen
supplement
tabl
fig
result
spike
glycoprotein
report
tabl
structur
align
reveal
proteas
highli
conserv
sar
pdb
main
proteas
id
pro
main
proteas
run
restrict
minim
process
util
schroding
dock
fig
previou
studi
reveal
sar
proteas
mutat
residu
render
enzym
inact
homolog
residu
site
center
x
z
fig
use
central
point
molecular
dock
calcul
activ
site
also
reveal
second
histidin
center
site
center
x
z
fig
seem
play
role
interact
bound
ligand
structur
target
second
center
point
molecular
dock
calcul
result
proteas
report
tabl
molecular
dock
employ
search
possibl
medic
contain
approv
bioactiv
compound
databas
hit
compound
report
potenti
inhibit
spike
protein
pro
main
proteas
guarante
activ
howev
lay
groundwork
comput
drug
discoveri
new
compound
reduc
transmiss
symptom
use
structur
homolog
model
determin
dockabl
target
spike
protein
util
newli
character
pro
main
proteas
dock
model
sever
excit
hit
pro
main
proteinas
zanamivir
approv
medic
treatment
influenza
b
virus
indinavir
saquinavir
shown
treat
prevent
hiv
remdesivir
antivir
compound
experiment
stage
shown
activ
sarscoronaviru
ebola
viru
possibl
also
excit
uncov
flavin
adenin
dinucleotid
fad
adeflavin
defici
medicin
coenzym
coenzym
may
also
potenti
use
treatment
infect
